CONTACT

If you would like an application mailed to you or if you have any questions, please call the HDAP staff at 617.502.1700 (Toll free: 800.228.2714) or email info@crine.org.

Secure Email Instructions:

To submit client applications, forms or information via email, please use our secure email system by:

Logging into our secure email portal here: https://web1.zixmail.net/s/login?b=crine. If you have never logged in before, you will be prompted to set up an account. Follow the instructions here to send an email to the appropriate CRI team. http://www.uapguide.com/community-research-initiative-of-new-englandhdap/customer/introduction. Be sure to select the appropriate program you are trying to reach from the drop down menu.

For secure portal technical support (password resets, lock outs, etc.) please contact ZixCorp Support at 888.576.4949 or email: support@zixcorp.com.

OR

Replying to a secure email sent from CRI. This will take you directly to our secure email portal.

For specific questions on:

  • The status of pending applications or missing documents: Please call the HDAP staff at 617.502.1700 (Toll free: 800.228.2714) 
  • The Comprehensive Health Insurance Initiative (CHII) or other insurance questions: Please call CHII staff at 617.502.1700 (Toll free: 800.228.2714) 
  • Pharmacy information or other client services: Please call the HDAP staff at 617.502.1700 (Toll free: 800.228.2714) 
  • The Post-Exposure Prophylaxis (nPEP) or Pre-Exposure Prophylaxis (PrEP) programs: Please call Kevin Herwig at 617.502.1737 (email: kherwig@crine.org)
  • Specific claims or pharmacy billing questions: Please call Evelyn at 617.502.1741 (email: ecolon@crine.org)
  • The TB Drug Assistance Program: Please call Maia Tarnas at 617.502.1722 (email: mtarnas@crine.org)
  • Training and technical assistance on health insurance enrollment: Please call the BRIDGE team at 617.502.1700 (Toll free: 800.228.2714) 

If you have any questions, please contact info@crine.org and we will direct your question to the appropriate department.